Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism‐like phenotype in mice
暂无分享,去创建一个
J. Schulz | K. Nave | S. Goebbels | C. Preisinger | Sabitha Joseph | M. Mitkovski | T. Marquardt | P. Lingor | Camille Lancelin | L. Tatenhorst | S. Vingill | N. Schwedhelm-Domeyer | J. Stegmüller | David Brockelt | Guergana Dontcheva | Siv Vingill | Till Marquardt | Judith Stegmüller | Nicola Schwedhelm-Domeyer
[1] A. Sali,et al. The proteasomal subunit Rpn6 is a molecular clamp holding the core and regulatory subcomplexes together , 2011, Proceedings of the National Academy of Sciences.
[2] H. Yokosawa,et al. Assembly of the 26S proteasome is regulated by phosphorylation of the p45/Rpt6 ATPase subunit. , 2001, Biochemistry.
[3] J. Lowe,et al. Ubiquitin is a component of neurofibrillary tangles in a variety of neurodegenerative diseases , 1988, Neuroscience Letters.
[4] W. Oyen,et al. FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome , 2009, Neurology.
[5] Y. Itoyama,et al. Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(−)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease , 2003, Journal of the Neurological Sciences.
[6] J. Blesa,et al. α-Synuclein-Independent Histopathological and Motor Deficits in Mice Lacking the Endolysosomal Parkinsonism Protein Atp13a2 , 2015, The Journal of Neuroscience.
[7] Nicholas W Wood,et al. The Parkinson ’ s disease – linked proteins Fbxo 7 and Parkin interact to mediate mitophagy , 2022 .
[8] James Lowe,et al. Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies , 2008, The Journal of Neuroscience.
[9] 孙林,et al. Shewanella oneidensis MR-1对针铁矿的还原与汞的生物甲基化 , 2015 .
[10] M. Hochstrasser,et al. Molecular architecture and assembly of the eukaryotic proteasome. , 2013, Annual review of biochemistry.
[11] P. Cortelli,et al. A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism. , 2014, Parkinsonism & related disorders.
[12] E. Tolosa,et al. Intranigral infusion of interleukin‐1β activates astrocytes and protects from subsequent 6‐hydroxydopamine neurotoxicity , 2003, Journal of neurochemistry.
[13] J. Hazle,et al. The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis , 2012, Cell.
[14] H. Laman,et al. Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins , 2013, Open Biology.
[15] Timothy Cardozo,et al. Systematic analysis and nomenclature of mammalian F-box proteins. , 2004, Genes & development.
[16] A. Nicholas. Levodopa‐induced hyperactivity in mice treated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine , 2007, Movement disorders : official journal of the Movement Disorder Society.
[17] Timothy Cardozo,et al. The SCF ubiquitin ligase: insights into a molecular machine , 2004, Nature Reviews Molecular Cell Biology.
[18] Nobel C. Zong,et al. Lysine ubiquitination and acetylation of human cardiac 20S proteasomes , 2014, Proteomics. Clinical applications.
[19] A. Leutenegger,et al. A new F‐box protein 7 gene mutation causing typical Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[20] N. Hattori,et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin‐like domain , 2003, EMBO reports.
[21] Y. Agid,et al. A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations. , 2009, Parkinsonism & related disorders.
[22] G. Melino,et al. DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity , 2013, Oncotarget.
[23] Steven P Gygi,et al. A proteomics approach to understanding protein ubiquitination , 2003, Nature Biotechnology.
[24] Heidi Phillips,et al. Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.
[25] S. Henderson,et al. Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6 , 2005, The EMBO journal.
[26] David S. Park,et al. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] B. Monsarrat,et al. Affinity Purification Strategy to Capture Human Endogenous Proteasome Complexes Diversity and to Identify Proteasome-interacting Proteins*S , 2009, Molecular & Cellular Proteomics.
[28] M. Rapé,et al. Mechanism of Ubiquitin-Chain Formation by the Human Anaphase-Promoting Complex , 2008, Cell.
[29] J. Crabbe,et al. Ethanol's effects on gait dynamics in mice investigated by ventral plane videography. , 2004, Alcoholism, clinical and experimental research.
[30] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[31] Kaya Bilgüvar,et al. FBXO7-R498X mutation: phenotypic variability from chorea to early onset parkinsonism within a family. , 2014, Parkinsonism & related disorders.
[32] P. Kloetzel,et al. PI31 is a modulator of proteasome formation and antigen processing , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] I. Amende,et al. Journal of Neuroengineering and Rehabilitation Open Access Gait Dynamics in Mouse Models of Parkinson's Disease and Huntington's Disease Gait Variabilitygaitmouse Modelsneurodegenerationmovement Disordersamyotrophic Lateral Sclerosissod1 , 2022 .
[34] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[35] G. Lukács,et al. Site-specific ubiquitination exposes a linear motif to promote interferon-α receptor endocytosis , 2007, The Journal of cell biology.
[36] R. J. Kelleher,et al. Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice , 2010, Proceedings of the National Academy of Sciences.
[37] Xiaohua Li,et al. Molecular and Cellular Roles of PI31 (PSMF1) Protein in Regulation of Proteasome Function* , 2014, The Journal of Biological Chemistry.
[38] Edward L. Huttlin,et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. , 2011, Molecular cell.
[39] Bryan L Roth,et al. Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons* , 2003, Journal of Biological Chemistry.
[40] Jie Shen,et al. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress , 2008, Proceedings of the National Academy of Sciences.
[41] A. Singleton,et al. Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations , 2010, Movement disorders : official journal of the Movement Disorder Society.
[42] F. Tsai,et al. Skp2-Mediated RagA Ubiquitination Elicits a Negative Feedback to Prevent Amino-Acid-Dependent mTORC1 Hyperactivation by Recruiting GATOR1. , 2015, Molecular cell.
[43] M. Mann,et al. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.
[44] Chien-Feng Li,et al. Skp2-dependent ubiquitination and activation of LKB1 is essential for cancer cell survival under energy stress. , 2015, Molecular cell.
[45] Jeffrey N Keller,et al. Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover* , 2004, Journal of Biological Chemistry.
[46] M. Ronaghi,et al. Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. , 2008, American journal of human genetics.
[47] M. Beal,et al. Unexpected Lack of Hypersensitivity in LRRK2 Knock-Out Mice to MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine) , 2009, The Journal of Neuroscience.
[48] E. Morris,et al. Molecular model of the human 26S proteasome. , 2012, Molecular cell.
[49] B. Monsarrat,et al. Deciphering preferential interactions within supramolecular protein complexes: the proteasome case , 2015, Molecular systems biology.
[50] J. Murray-Rust,et al. Structure of a Conserved Dimerization Domain within the F-box Protein Fbxo7 and the PI31 Proteasome Inhibitor* , 2008, Journal of Biological Chemistry.
[51] B. Oostra,et al. Loss of Nuclear Activity of the FBXO7 Protein in Patients with Parkinsonian-Pyramidal Syndrome (PARK15) , 2011, PloS one.
[52] I. Amende,et al. Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome , 2004, Physiology & Behavior.
[53] M. Glickman,et al. Reversible 26S proteasome disassembly upon mitochondrial stress. , 2014, Cell reports.
[54] M. Mann,et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.
[55] W. Kolch,et al. On-Beads Digestion in Conjunction with Data-Dependent Mass Spectrometry: A Shortcut to Quantitative and Dynamic Interaction Proteomics , 2014, Biology.
[56] D. Finley,et al. Recognition and processing of ubiquitin-protein conjugates by the proteasome. , 2009, Annual review of biochemistry.
[57] S. Elledge,et al. Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex , 2002, Nature.
[58] Dmitry Grapov. DeviumWeb: version 0.3.2 , 2014 .
[59] C. Sortwell,et al. Oligodendrocyte‐type 2 astrocyte‐derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell death , 2000, The Journal of comparative neurology.
[60] Ron Wehrens,et al. Chemometrics with R: Multivariate Data Analysis in the Natural Sciences and Life Sciences , 2011 .
[61] A. Ciechanover,et al. Ubiquitin‐mediated proteolysis: biological regulation via destruction , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[62] O. Levy,et al. The neuropathology of genetic Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[63] F. Förster,et al. Unveiling the long-held secrets of the 26S proteasome. , 2013, Structure.
[64] D. Sulzer,et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. , 2000, Neuron.
[65] O. Hermanson,et al. Genetic targeting of principal neurons in neocortex and hippocampus of NEX‐Cre mice , 2006, Genesis.
[66] T. Dawson,et al. Bcl-x Is Required for Proper Development of the Mouse Substantia Nigra , 2005, The Journal of Neuroscience.
[67] C. Pickart,et al. Ubiquitin in chains. , 2000, Trends in biochemical sciences.
[68] C. Tanner,et al. Levodopa and the progression of Parkinson's disease. , 2004, The New England journal of medicine.
[69] S. Vaulont,et al. Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene. , 2000, Nucleic acids research.